Quidel Corporation (NASDAQ:QDEL) SVP Werner Kroll sold 7,565 shares of Quidel Corporation stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $39.50, for a total value of $298,817.50. Following the transaction, the senior vice president now owns 10,261 shares in the company, valued at approximately $405,309.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Shares of Quidel Corporation (NASDAQ QDEL) opened at $38.92 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 6.28 and a quick ratio of 5.68. Quidel Corporation has a 1 year low of $18.25 and a 1 year high of $45.55.

Quidel Corporation (NASDAQ:QDEL) last posted its quarterly earnings data on Wednesday, November 1st. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.21). The firm had revenue of $50.89 million during the quarter, compared to analysts’ expectations of $50.47 million. Quidel Corporation had a negative net margin of 2.33% and a negative return on equity of 2.36%. Quidel Corporation’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.10 EPS. equities analysts predict that Quidel Corporation will post 0.6 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Werner Kroll Sells 7,565 Shares of Quidel Corporation (QDEL) Stock” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.watchlistnews.com/werner-kroll-sells-7565-shares-of-quidel-corporation-qdel-stock/1693142.html.

QDEL has been the topic of a number of research analyst reports. Barclays PLC restated a “buy” rating and issued a $45.00 target price (up previously from $39.00) on shares of Quidel Corporation in a research report on Tuesday, September 19th. Raymond James Financial, Inc. restated a “buy” rating and issued a $47.00 target price (up previously from $41.00) on shares of Quidel Corporation in a research report on Tuesday, September 19th. Canaccord Genuity upgraded Quidel Corporation from a “hold” rating to a “buy” rating in a research report on Tuesday, July 18th. Zacks Investment Research upgraded Quidel Corporation from a “hold” rating to a “buy” rating and set a $30.00 target price on the stock in a research report on Tuesday, July 18th. Finally, BidaskClub downgraded Quidel Corporation from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 16th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $48.80.

Several hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Quidel Corporation by 3.2% in the 2nd quarter. Vanguard Group Inc. now owns 2,195,101 shares of the company’s stock valued at $59,575,000 after buying an additional 68,549 shares during the period. Macquarie Group Ltd. raised its holdings in shares of Quidel Corporation by 8.1% in the 2nd quarter. Macquarie Group Ltd. now owns 1,292,492 shares of the company’s stock valued at $35,078,000 after buying an additional 96,565 shares during the period. New York State Common Retirement Fund raised its holdings in shares of Quidel Corporation by 0.7% in the 3rd quarter. New York State Common Retirement Fund now owns 899,390 shares of the company’s stock valued at $39,447,000 after buying an additional 6,635 shares during the period. Fred Alger Management Inc. raised its holdings in shares of Quidel Corporation by 0.4% in the 2nd quarter. Fred Alger Management Inc. now owns 672,880 shares of the company’s stock valued at $18,262,000 after buying an additional 2,757 shares during the period. Finally, Renaissance Technologies LLC raised its holdings in shares of Quidel Corporation by 27.6% in the 2nd quarter. Renaissance Technologies LLC now owns 612,487 shares of the company’s stock valued at $16,623,000 after buying an additional 132,587 shares during the period. Hedge funds and other institutional investors own 86.82% of the company’s stock.

Quidel Corporation Company Profile

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Insider Buying and Selling by Quarter for Quidel Corporation (NASDAQ:QDEL)

Receive News & Ratings for Quidel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.